The U.S. Food and Drug Administration has approved Deucravacitinib (Sotyktu) for the treatment of adults with Psoriatic Arthritis. This oral drug is a selective TYK2 inhibitor and had ...

Combined assessment using MSUS semiquantitative scores and inflammatory biomarkers may improve diagnostic accuracy and ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced that the US ...

If the sBLA is approved, expansion into psoriatic arthritis would build on the established clinical experience of ILUMYA as an IL-23 inhibitor for moderate-to-severe ...

Recruitment for the rheumatoid arthritis (RA) sub-study of the SKYWAY basket trial is complete; Week 12 topline data now expected in Q3 2026 ...

A new case study documents six months of complete pain relief in an 80-year-old man with arthritis, achieved without ...

Sun Pharmaceutical Industries Limited said on Monday, March 16, that the US Food and Drug Administration has accepted for review a supplemental Biologics License Application (sBLA) for ILUMYA.

I'm almost 69 and close to retirement, but I can't seem to pull the trigger. I'm currently employed as a design engineer, and my salary is pretty decent. I'm married, and my wife works one day a week ...

Aussie sprint sensation Gout Gout has won the 100m and 200m event at the Queensland athletics championships and legendary sports commentator Bruce McAvaney made the trip to watch the superstar. The 19 ...

BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.

The teenager took the 200m title with a time of 20.42 seconds after running into a headwind at the Queensland Athletic ...

John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking ...